Millrace Asset Group, Inc. Neogenomics Inc Transaction History

Millrace Asset Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$11.67 - $20.73 $287,607 - $510,890	24,645 New	24,645 $399,000
Q1 2018 May 15, 2018	SELL	$7.23 - $8.76 $343,916 - $416,695	-47,568 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$8.02 - $11.18 $552,209 - $769,787	-68,854 Reduced 59.14%	47,568 $421,000
Q3 2017 Nov 13, 2017	SELL	$9.11 - $11.26 $533,645 - $659,588	-58,578 Reduced 33.47%	116,422 $1.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	175,000	175,000 $1.57 Million

291

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.82B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Millrace Asset Group, Inc. with notifications on news.